新闻中心
NEWS
新闻中心

2021-010 Yan'an Pharmaceutical: Announcement of Resolutions of the Thirteenth Meeting of the Second Board of Directors


classification: Notice

Time:2021-10-25 11:15

1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: April 19, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site
4. Time and method of issuing notice of board meeting: April 9, 2021 by mail
5. Moderator of the meeting: Chairman Wang Xueliang
6. People attending the meeting (if any): all supervisors, senior management
7. Explanation of the legality, compliance and constitutionality of the convening:
The convening and convening procedures of this meeting, the qualifications of attending the meeting and the qualifications of the convener, and the voting procedures of the meeting are in compliance with the "Company Law of the People's Republic of China", "Articles of Association" and relevant laws, regulations and regulations, and the resolutions made are legal and valid.

(2) Meeting attendance
7 directors should be present at the meeting, and 7 directors should be present and authorized to attend.
Director Wang Zheng and Sun Pengjun were absent due to personal reasons and entrusted Director Wang Xueliang to vote on their behalf (if any).
2. Review of the proposal
(1) Review and approve the "2020 Annual Report and its Summary" proposal
1. The content of the proposal:
The report has been disclosed in the "Annual Report 2020" (Announcement No.: 2021-011) and the "Summary of the 2020 Annual Report" (Announcement Number: 2021-012).
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(2) The proposal of "Special Report on Capital Occupation in 2020" was considered and passed
1. The content of the proposal:
The report has been disclosed in the "Special Report on Capital Occupation for 2020" (Announcement No.: 2021-016) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn).
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(3) Review and pass the "2020 Board of Directors Work Report" proposal
1. The content of the proposal:
The company's board of directors reviewed and discussed the work in 2020, and formed the work report of the board of directors in 2020.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(4) The proposal of "2020 Annual General Manager Work Report" was considered and passed
1. The content of the proposal:
The general manager reviewed and summarized the work in 2020 and looked forward to the work in 2021.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
(5) Review and approve the "2020 Financial Statements Report" proposal
1. The content of the proposal:
The company has summarized the company's 2020 financial status based on the actual situation, and made a 2020 financial statement report.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(6) The proposal of "2021 Financial Budget Report" was considered and passed
1. The content of the proposal:
According to the company's 2020 financial statement report and the company's actual situation and subsequent development, the company has formulated the 2021 financial budget.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(7) The proposal of "2020 Profit Distribution Plan" was considered and passed
1. The content of the proposal:
According to the company's operating conditions and the "audit report" issued by Lixin Certified Public Accountants (special general partnership), for the long-term development of the company, no profit distribution will be made in 2020.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(8) Deliberated and approved the "Regarding the Renewal of the Appointment of Audit Institutions for 2021"
1. The content of the proposal:
It is proposed to hire Lixin Certified Public Accountants (special general partnership) as the audit agency in 2021.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
(9) The proposal of "Special Report on the Deposit and Actual Use of Raised Funds in 2020" was considered and approved
1. The content of the proposal:
The report has been disclosed in the "Special Report on the Deposit and Actual Use of Raised Funds in 2020" published on the Information Disclosure Platform of the National Small and Medium-sized Enterprise Share Transfer System (www.neeq.com.cn) (Announcement No.: 2021-017)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
(10) Deliberated and approved the "About Appointment of the Secretary of the Company's Board of Directors"
1. The content of the proposal:
The report has been disclosed in the "Announcement on Appointment of Senior Managers" (Announcement No.: 2021-014) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
(11) The proposal of "Agreeing to Provide Guarantee for Shanghai Yan'an Pharmaceutical Co., Ltd."
1. The content of the proposal:
The company agreed to provide guarantee guarantee for the loan of Shanghai Rural Commercial Bank Co., Ltd. Minhang Branch by Shanghai Yan’an Pharmaceutical Co., Ltd. Water, electricity, rent, etc. (specifically subject to each loan guarantee contract signed by the company and your bank after your bank’s approval), the term is one year.
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
(12) Deliberated and approved the proposal of "Applying to the Company's 2020 Annual General Meeting of Shareholders"
1. The content of the proposal:
The report has been disclosed in the "Notice on Convening the 2020 Annual General Meeting of Shareholders" (Announcement No.: 2021-013) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn)
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
3. List of available documents
Resolutions of the thirteenth meeting of the second board of directors of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd.

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
April 20, 2021

Back list